HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

S 28690

Also Known As:

S-28690; S28690

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - S 28690: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - S 28690: 1

Experts

1.	Hammond, Caitlin: 1 article (03/2006)
2.	He, Liwei: 1 article (03/2006)
3.	Mena, Jenny: 1 article (03/2006)
4.	Miller, Richard L: 1 article (03/2006)
5.	Shi, Yonghong: 1 article (03/2006)
6.	Spaner, David E: 1 article (03/2006)
7.	Tomic, Jelena: 1 article (03/2006)
8.	White, Dionne: 1 article (03/2006)

Related Diseases

1.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/15/2006 - "Because signals from both the innate and adaptive immune systems direct the acquisition of strong immunogenicity by professional APCs, the effects of IL-2 and the TLR-7 agonist, S28690, on the immunogenic properties of chronic lymphocytic leukemia (CLL) B cells were studied. "

Related Drugs and Biologics

1.	Interleukin-2 (IL2)